(SINV (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (QP (JJR more) (IN than) (CD 850,000)))))) (VP (VP (VBD confirmed) (NP (NNS cases))) (CC and) (VP (PP (IN over) (NP (CD 48,000) (NNS deaths))) (PP (IN from) (NP (DT the) (JJ human) (NN coronavirus) (NN disease) (CD 2019) (PRN (-LRB- -LRB-) (NP (NN COVID) (HYPH -) (CD 19)) (-RRB- -RRB-)))))) (NP (NP (NN pandemic)) (, ,) (VP (VBN caused) (PP (IN by) (NP (NP (NP (JJ novel) (ADJP (JJ severe) (JJ acute)) (JJ respiratory) (NN syndrome) (NN coronavirus)) (-LRB- -LRB-) (NP (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (CD 2)) (-RRB- -RRB-)) (, ,) (PP (IN in) (NP (DT the) (NNP United) (NNP States))))) (ADVP (RB alone)))) (. .))
(S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (ADVP (RB currently)) (NP (NP (DT no) (JJ proven) (JJ effective) (NNS medications)) (PP (IN against) (NP (NNP COVID) (HYPH -) (NNP 19))))) (. .))
(FRAG (NP (NN Drug)) (NP (NP (VBG repurposing) (NNS offers)) (NP (NP (DT a) (JJ promising) (NN way)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NML (NN prevention) (CC and) (NN treatment)) (NNS strategies)) (PP (IN for) (NP (NN COVID) (HYPH -) (CD 19))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ reports) (NP (DT an) (JJ integrative) (, ,) (ADJP (NN network) (HYPH -) (VBN based)) (NML (JJ deep) (NN learning)) (NN methodology)) (S (VP (TO to) (VP (VB identify) (NP (JJ repurposable) (NNS drugs)) (PP (IN for) (NP (NN COVID) (HYPH -) (CD 19)))))) (PRN (-LRB- -LRB-) (S (VP (VBN termed) (NP (NN CoV) (HYPH -) (NN KGE)))) (-RRB- -RRB-))) (. .))
(S (ADVP (RB Specifically)) (, ,) (NP (PRP we)) (VP (VBD built) (NP (NP (DT a) (JJ comprehensive) (NN knowledge) (NN graph)) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (QP (CD 15) (CD million)) (NNS edges)) (PP (IN across) (NP (NP (CD 39) (NNS types)) (PP (IN of) (NP (NP (NNS relationships)) (VP (VBG connecting) (NP (NNS drugs) (, ,) (NNS diseases) (, ,) (NNS genes) (, ,) (NNS pathways) (, ,) (CC and) (NNS expressions))))))) (, ,) (PP (IN from) (NP (NP (DT a) (JJ large) (JJ scientific) (NN corpus)) (PP (IN of) (NP (QP (CD 24) (CD million)) (NNP PubMed) (NNS publications)))))))))) (. .))
(S (S (VP (VBG Using) (NP (NP (NNP Amazon) (NNP AWS)) (NP (NN computing) (NNS resources))))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (CD 41) (JJ repurposable) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NN indomethacin) (, ,) (NN toremifene) (CC and) (NN niclosamide))) (-RRB- -RRB-)) (SBAR (WHNP (WHNP (WP$ whose) (NML (JJ therapeutic) (NN association))) (PP (IN with) (NP (NN COVID) (HYPH -) (CD 19)))) (S (VP (VBD were) (VP (VBN validated) (PP (IN by) (NP (ADJP (JJ transcriptomic) (CC and) (JJ proteomic)) (NNS data))) (PP (IN in) (NP (NP (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (NNP 2)) (SBAR (S (VP (VBD infected) (NP (JJ human) (NNS cells) (CC and) (NNS data)) (PP (IN from) (NP (JJ ongoing) (JJ clinical) (NNS trials)))))))))))))) (. .))
(S (SBAR (IN While) (S (NP (NP (DT this) (NN study)) (, ,) (PP (IN by) (NP (DT no) (NNS means)))) (VP (VBZ recommends) (NP (JJ specific) (NNS drugs))))) (, ,) (NP (PRP it)) (VP (VBZ demonstrates) (NP (DT a) (JJ powerful) (NML (JJ deep) (NN learning)) (NN methodology)) (PP (IN to) (VP (VB prioritize) (NP (VBG existing) (NNS drugs)) (PP (IN for) (NP (NP (JJ further) (NN investigation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ holds) (NP (NP (DT the) (NN potential)) (PP (IN of) (S (VP (VBG accelerating) (NP (JJ therapeutic) (NN development)) (PP (IN for) (NP (NN COVID) (HYPH -) (CD 19))))))))))))))) (. .))
